Search results for " Ly"

showing 10 items of 2487 documents

Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DA…

2016

Abstract Background: While first line therapy for FL with chemotherapy or chemoimmunotherapy produces durable responses, most patients (pts) with FL eventually relapse. Those who become resistant to chemoimmunotherapy have limited treatment options. Ibrutinib, an inhibitor of BTK (Bruton's tyrosine kinase) and ITK (interleukin-2-inducible T-cell kinase), has demonstrated robust clinical activity in various B-cell non-Hodgkin lymphomas. Previous Phase 1 and 2 studies have shown promising results with single-agent ibrutinib in pts with relapsed or refractory FL (Bartlett NL. Blood. 2014; 800 & Fowler N. Blood. 2015; 2706). The aim of the DAWN study was to provide additional efficacy and s…

medicine.medical_specialtyImmunologyPopulationFollicular lymphomaPhases of clinical researchBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineChemoimmunotherapyPartial responseInternal medicinemedicineeducationeducation.field_of_studybusiness.industryCell BiologyHematologymedicine.diseaseRegimenchemistry030220 oncology & carcinogenesisIbrutinibImmunologybusinessProgressive disease030215 immunologyBlood
researchProduct

Idiopathic thrombotic thrombocytopenic purpura: strongest risk factor for relapse from remission is having had a relapse

2016

BACKGROUND Thrombotic thrombocytopenic purpura (TTP) is a rare, episodic clinical syndrome involving the production of thrombi in the microvasculature accompanied by thrombocytopenia and symptoms of organ ischemia. Idiopathic TTP develops when a patient produces antibodies that react with the protease ADAMTS13. The course after an episode is unpredictable; patients may relapse frequently or never. There is no laboratory value that can reliably predict potential relapse. STUDY DESIGN AND METHODS To assess diagnostic and predictive values for risk of relapse, plasma samples from 27 patients with idiopathic TTP in remission were analyzed for anti-ADAMTS13 immunoglobulin (Ig)G, ADAMTS13 activit…

medicine.medical_specialtyImmunologyThrombotic thrombocytopenic purpuraIschemiaDisease030204 cardiovascular system & hematologyBethesda unitGastroenterology03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesInternal medicineImmunology and AllergyMedicineRisk factorHematologybiologybusiness.industryHematologymedicine.diseaseADAMTS13Immunologybiology.proteinAntibodybusiness030215 immunologyTransfusion
researchProduct

Bilateral jaws involvement of Burkitt?s lymphoma in a pediatric patient

2021

A case of Burkitt’s lymphoma with bilateral jaws involvement in a 5-year-old boy is reported discussing the dentist’s role in the diagnosis and management of this disease. The initial clinical diagnosis established of maxillary swelling causing trismus was a dentoalveolar abscess. The incisional biopsy was performed and histopathological analysis, including immunohistochemistry, confirmed the Burkitt’s lymphoma. The patient underwent treatment and remains free of the disease for 36 months of follow-up. The occurrence of intraoral bilateral jaws involvement of Burkitt’s lymphoma in child is unusual and its accurate diagnosis avoids complications in the patient’s treatment. Key words:Burkitt’…

medicine.medical_specialtyIncisional biopsyOral Medicine and Pathologybusiness.industryCase Reportmedicine.diseaseTrismusLymphomaSurgeryPediatric patientimmune system diseasesMaxillary swellinghemic and lymphatic diseasesMaxillamedicineMAXILAmedicine.symptomAbscessbusinessGeneral DentistryBurkitt's lymphomaUNESCO:CIENCIAS MÉDICAS
researchProduct

Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced F…

2018

Abstract Introduction: Advanced follicular lymphoma (FL) is a clinically and molecularly heterogeneous disease. About 20% of patients have early progression of disease (POD) and short overall survival (OS). We have previously shown that integration of lymphoma-specific gene mutations and clinical factors improves pretreatment risk stratification (Pastore, 2015) and prediction of early POD (i.e., within 24 months, POD24; Jurinovic, 2016). Recently, we have shown that high-dose therapy (HDT) followed by autologous stem-cell transplantation (ASCT) is an effective treatment option for eligible patients with high-risk disease as defined by POD24 (Jurinovic, 2018). Here, we aimed to explore wheth…

medicine.medical_specialtyIntention-to-treat analysisbusiness.industryImmunologyFollicular lymphomaCell BiologyHematologyGene mutationmedicine.diseaseBiochemistryTransplantationAutologous stem-cell transplantationInternational Prognostic IndexInternal medicineCohortmedicineIn patientbusinessBlood
researchProduct

Robotic Hysterectomy in Severely Obese Patients With Endometrial Cancer: A Multicenter Study

2015

Abstract Study Objective The aim of this study was to evaluate the surgical and oncologic outcomes of robotic hysterectomy with or without or less pelvic and aortic lymphadenectomy in severely obese patients (body mass index [BMI] ≥ 40 kg/m 2 ) with endometrial cancer. Material and Methods Between August 2010 and November 2014, patients with histologically confirmed endometrial cancer and BMI ≥40 kg/m 2 were deemed eligible for the study and underwent RH with or without pelvic and aortic lymphadenectomy. Results Seventy patients were divided into 3 groups according to their BMI: group A, BMI between 40 and 45 kg/m 2 (50 patients); group B, BMI between 45 and 50 kg/m 2 (10 patients); and gro…

medicine.medical_specialtyIntraoperative Complicationmedicine.medical_treatmentHysterectomyBody Mass Index03 medical and health sciencesPostoperative Complications0302 clinical medicineRobotic Surgical ProceduresEndometrial cancerLaparotomymedicineHumansObesityRobotic hysterectomyMorbidIntraoperative ComplicationsLaparoscopyAged030219 obstetrics & reproductive medicineHysterectomymedicine.diagnostic_testbusiness.industryMedicine (all)Endometrial cancerObstetrics and GynecologyPostoperative complicationLength of StayMiddle Agedmedicine.diseaseEndometrial NeoplasmsObesity MorbidSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIA030220 oncology & carcinogenesisLymph Node ExcisionFemaleLaparoscopyLymphadenectomyEndometrial cancer; Morbidity obese; Robotic hysterectomy; Aged; Body Mass Index; Endometrial Neoplasms; Female; Humans; Intraoperative Complications; Length of Stay; Lymph Node Excision; Middle Aged; Obesity Morbid; Postoperative Complications; Hysterectomy; Laparoscopy; Robotic Surgical Procedures; Obstetrics and Gynecology; Medicine (all)businessBody mass indexMorbidity obeseJournal of Minimally Invasive Gynecology
researchProduct

Transperitoneal versus extraperitoneal laparoscopic aortic lymph nodal staging for locally advanced cervical cancer: A systematic review and meta-ana…

2021

Abstract Cervical cancer is the fourth most common neoplasm in women. In locally advanced cervical cancers, the international guidelines recommend nodal aortic assessment. Two techniques have been described to perform laparoscopic aortic lymphadenectomy: transperitoneal laparoscopic lymphadenectomy (TLL) and extraperitoneal laparoscopic lymphadenectomy (ELL). This meta-analysis aims to compare the surgical outcomes of TLL and ELL for staging purposes. The systematic review was carried out in agreement with the preferred reporting items for systematic reviews and meta-analyses statement (PRISMA). Two hundred and twenty studies were analyzed, and 19 studies were included in the review (7 for …

medicine.medical_specialtyIntraoperative Complicationmedicine.medical_treatmentUterine Cervical Neoplasms03 medical and health sciencesPostoperative Complications0302 clinical medicineExtraperitonealLaparotomyAortic lymphadenectomymedicineHumansMinimally invasiveIntraoperative ComplicationsLymph nodeAortaNeoplasm StagingCervical cancerUterine Cervical Neoplasms...030219 obstetrics & reproductive medicinebusiness.industryPostoperative complicationGeneral Medicinemedicine.diseaseSurgeryLaparoscopic stagingmedicine.anatomical_structureOncology030220 oncology & carcinogenesisMeta-analysisLymph Node ExcisionFemaleLaparoscopySurgeryLymphadenectomyLymph NodesLymphPeritoneumbusinessEuropean Journal of Surgical Oncology
researchProduct

Anderson‐Fabry Disease: A Rare Cause of Levodopa‐Responsive Early‐Onset Parkinsonism

2021

NA

medicine.medical_specialtyLevodopabusiness.industryEarly onset parkinsonismGastroenterologyAnderson-Fabry DiseaseNeurologyInternal medicinemedicineAnderson-Fabry disease early onset parkinsonism levodopa response lysosomal storage diseasesSettore MED/26 - NeurologiaNeurology (clinical)businessCase Reports and Commentariesmedicine.drugMovement Disorders Clinical Practice
researchProduct

Applicability of the STOPP/START criteria to older polypathological patients in a long-term care hospital

2017

Objectives To analyse the applicability of the STOPP/START criteria as a tool to identify patients with potentially inappropriate medications (PIM) during pharmaceutical validation of prescriptions in a long-term care hospital, to identify risk factors for PIM and to characterise the physiological systems and drugs more frequently associated with these PIM. Methods An interventional, prospective and longitudinal study was conducted in polypathological patients aged >65 years. Usual pharmaceutical care and the STOPP/START criteria were used to identify PIM and to plan pharmaceutical interventions at admission. At discharge, the discharge summaries were reviewed using the STOPP/START criteria…

medicine.medical_specialtyLongitudinal studybusiness.industrySTOPP START CriteriaStopp criteriaPsychological intervention030204 cardiovascular system & hematologymedicine.diseaseComorbidity03 medical and health sciencesLong-term care0302 clinical medicinePharmaceutical carehemic and lymphatic diseasesmedicineOriginal Article030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsMedical prescriptionIntensive care medicinebusinessEuropean Journal of Hospital Pharmacy
researchProduct

Primary spinal Burkitt’s lymphoma: Case report and literature review

2021

Background:Burkitt’s lymphoma is a non-Hodgkin B-cell lymphoma, occurring mostly in Equatorial Africa. According to the WHO, classification is three different variants: sporadic, endemic, and immunodeficient-associated. Here, we present a patient with “sporadic” primary epidural Burkitt’s lymphoma resulting in chronic low back pain (LBP).Case Description:A 63-year-old female presented with a 2-month history of LBP and the left lower extremity sciatica. The thoracolumbar MRI showed a L5 irregular, osteolytic epidural lesion that was hypointense on T1-weighted images, hyperintense on STIR studies, and inhomogeneously enhanced with contrast. Additional hypointense lesions were also seen at the…

medicine.medical_specialtyLymphomaRadiofrequency ablationmedicine.medical_treatmentCase Reportlaw.inventionLesion03 medical and health sciences0302 clinical medicinelawimmune system diseaseshemic and lymphatic diseasesMedicineChemotherapyBurkitt030212 general & internal medicineSciaticabusiness.industryLaminectomyLaminectomymedicine.diseaseSpineLymphomaRadiation therapySurgeryNeurology (clinical)Radiologymedicine.symptombusinessBurkitt's lymphoma030217 neurology & neurosurgeryChemoradiotherapySurgical Neurology International
researchProduct

Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now.

2017

The indolent non-Hodgkin lymphomas (i-NHLs) are characterised by ‘indolent’ clinical behaviour with slow growth and prolonged natural history. The watchful waiting (WW) strategy is a frequently employed treatment option in these patients. This implies a strict monitoring by imaging examinations, including 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) and CT. A major concern is radiation exposure due to regularly monitoring by conventional imaging procedures. Several studies have demonstrated the reliability of whole-body magnetic resonance imaging (WB-MRI) for lymphoma staging. WB-MRI could be useful for active surveillance in i-NHLs providing the …

medicine.medical_specialtyLymphomamedicine.medical_treatmentWhole body imaging030218 nuclear medicine & medical imaging03 medical and health sciencesMagnetic resonance imaging0302 clinical medicineimmune system diseaseshemic and lymphatic diseasesmedicinemedia_common.cataloged_instanceHumansRadiology Nuclear Medicine and imagingWhole Body ImagingEuropean unionWatchful WaitingNeuroradiologymedia_commonmedicine.diagnostic_testbusiness.industryLymphoma Non-HodgkinReproducibility of ResultsMagnetic resonance imagingInterventional radiologyGeneral Medicinemedicine.diseaseLymphomaRadiation therapyDiffusion Magnetic Resonance Imaging030220 oncology & carcinogenesisDisease ProgressionIonising radiationRadiologybusinessWatchful waitingEuropean radiology
researchProduct